APTOSE BIOSCIENCES INC's ticker is and the CUSIP is 03835T200. A total of 53 filers reported holding APTOSE BIOSCIENCES INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2023 | $352,000 | +10.3% | 550,000 | 0.0% | 0.04% | -27.4% |
Q4 2022 | $319,000 | -10.6% | 550,000 | -8.3% | 0.06% | -39.2% |
Q3 2022 | $357,000 | -31.2% | 600,000 | -14.3% | 0.10% | -39.3% |
Q2 2022 | $519,000 | -30.6% | 700,010 | +27.3% | 0.17% | -28.5% |
Q1 2022 | $748,000 | +0.7% | 550,000 | 0.0% | 0.24% | +2.2% |
Q4 2021 | $743,000 | +405.4% | 550,000 | +713.6% | 0.23% | +283.3% |
Q3 2021 | $147,000 | -89.5% | 67,600 | -83.9% | 0.06% | -89.7% |
Q2 2021 | $1,395,000 | -46.9% | 420,161 | -4.5% | 0.58% | -47.1% |
Q1 2021 | $2,629,000 | -16.1% | 440,000 | -38.5% | 1.10% | -30.6% |
Q4 2020 | $3,132,000 | -23.5% | 715,000 | +4.7% | 1.58% | -32.4% |
Q3 2020 | $4,096,000 | +60.3% | 682,579 | +68.5% | 2.34% | +36.7% |
Q2 2020 | $2,556,000 | +36.5% | 405,000 | -23.8% | 1.71% | -31.7% |
Q1 2020 | $1,873,000 | +8.1% | 531,200 | +73.8% | 2.50% | +859.0% |
Q4 2019 | $1,732,000 | – | 305,600 | – | 0.26% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Corriente Advisors, LLC | 2,900,000 | $12,702,000 | 3.02% |
P.A.W. CAPITAL CORP | 750,000 | $3,285,000 | 2.90% |
Prosight Management, LP | 824,795 | $3,613,000 | 1.67% |
Voss Capital, LLC | 715,000 | $3,132,000 | 1.58% |
DRW Securities, LLC | 7,976,176 | $34,936,000 | 1.23% |
Ally Bridge Group (NY) LLC | 1,409,150 | $6,172,000 | 1.06% |
Nantahala Capital Management | 7,272,673 | $31,854,000 | 0.99% |
SANDERS MORRIS HARRIS LLC | 925,153 | $4,231,000 | 0.96% |
PRECEPT MANAGEMENT LLC | 440,696 | $1,930,000 | 0.78% |
Endurant Capital Management LP | 477,895 | $2,093,000 | 0.76% |